Meadowbrook Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Meadowbrook Wealth Management's LLY Position: Q3 2026 in Review
Meadowbrook Wealth Management reduced its Eli Lilly (LLY) stake by 26% in Q3 2026, selling an estimated $1.02M and leaving 2,407 shares worth $2.79M. The position accounts for 2.92% of the portfolio, ranked #9.
Meadowbrook Wealth Management first reported a position in LLY in Q3 2025 and has held it in 5 quarters since. The position peaked at $3.92M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Meadowbrook Wealth Management held 2,407 shares of Eli Lilly worth $2.79M as of Q3 2026.
- Meadowbrook Wealth Management sold 861 Eli Lilly shares in Q3 2026, an estimated $1.02M.
- Eli Lilly made up 2.92% of Meadowbrook Wealth Management's portfolio in Q3 2026, its #9 holding.
- Meadowbrook Wealth Management first reported a position in Eli Lilly in Q3 2025 and has held it in 5 quarters since.
- Meadowbrook Wealth Management's Eli Lilly position peaked at $3.92M in Q2 2026.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Meadowbrook Wealth Management's 13F filing for Q3 2026, filed 8 Oct 2026.